Yangle Li
Impact in
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- Circular RNAs in diseases
- RNA modifications and cancer
- Epigenetics and DNA Methylation
Papers in
-
- Cancer-related molecular mechanisms research 5
- MicroRNA in disease regulation 3
- Surgery 13
- Bladder and Urothelial Cancer Treatments 6
- Genital Health and Disease 5
- Urinary and Genital Oncology Studies 2
- Co-authors
- Xiheng Hu (15 shared papers)Xiaokun Zhao (3 shared papers)Zhaohui Zhong (3 shared papers)Xiongbing Zu (10 shared papers)Songchao Li (2 shared papers)Yi Wang (1 shared paper)Miao Mo (6 shared papers)Jun Fu (4 shared papers)
- Journals
- Urologic Oncology Seminars and Original Investigations (2 papers)Bioscience Reports (1 paper)Journal of Cancer (1 paper)Cell Death and Disease (1 paper)Oncology Reports (1 paper)
- Partner nations
- China
In The Last Decade
Yangle Li
30 papers receiving 422 citations
Peers
Comparison fields: 5 of 53
- Cancer Research 141
- Molecular Biology 183
- Urology 15
- Surgery 101
- Pulmonary and Respiratory Medicine 72
Countries citing papers authored by Yangle Li
This map shows the geographic impact of Yangle Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yangle Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yangle Li more than expected).
Fields of papers citing papers by Yangle Li
This network shows the impact of papers produced by Yangle Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yangle Li. The network helps show where Yangle Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Yangle Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 74 | |
| 2 | 2019 | 34 | |
| 3 | 2021 | 27 | |
| 4 | 2021 | 21 | |
| 5 | 2011 | 21 | |
| 6 | 2025 | 20 | |
| 7 | 2020 | 20 | |
| 8 | 2019 | 20 | |
| 9 | 2014 | 19 | |
| 10 | 2018 | 18 | |
| 11 | 2022 | 15 | |
| 12 | 2020 | 13 | |
| 13 | 2019 | 13 | |
| 14 | 2023 | 13 | |
| 15 | 2011 | 12 | |
| 16 | 2020 | 11 | |
| 17 | 2020 | 10 | |
| 18 | 2019 | 8 | |
| 19 | 2013 | 8 | |
| 20 | 2021 | 7 |
About Yangle Li
Yangle Li is a scholar working on Cancer Research, Surgery, Oncology, Pulmonary and Respiratory Medicine and Biotechnology, having authored 30 papers that have together received 427 indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (6 papers), Cancer-related molecular mechanisms research (5 papers), Genital Health and Disease (5 papers), MicroRNA in disease regulation (3 papers), Circular RNAs in diseases (2 papers), Urinary and Genital Oncology Studies (2 papers), Cancer Immunotherapy and Biomarkers (2 papers) and Prostate Cancer Treatment and Research (1 paper). The work is most often cited by research in Cancer Research (141 citations), Molecular Biology (183 citations), Urology (15 citations), Surgery (101 citations) and Pulmonary and Respiratory Medicine (72 citations). Yangle Li has collaborated with scholars based in China. Frequent co-authors include Xiheng Hu, Xiaokun Zhao, Zhaohui Zhong, Xiongbing Zu, Songchao Li, Yi Wang, Miao Mo, Jun Fu, Wei He and Shiyu Tong. Their work appears in journals such as Urologic Oncology Seminars and Original Investigations, Bioscience Reports, Journal of Cancer, Cell Death and Disease and Oncology Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.